Recap of the Midterm Review Recommendations

Slides:



Advertisements
Similar presentations
One country platform for information and accountability From Brussels to Nairobi Fourth IHP+ Country Health Sector Teams Meeting Accelerating progress,
Advertisements

Information technology for surveillance Can information tools improve surveillance? Denis Coulombier ECDC.
GAVI Support and the Health Information System
Global Measles and Rubella Strategic Plan
Immunization Services DR. KANUPRIYA CHATURVEDI DR.S.K. CHATURVEDI.
Maternal, neonatal, child health and nutrition
EU and Wider Neighborhood Ukraine. EU and Wider Neighborhood Health Gap Main problem –premature adult morbidity and mortality Economic issue –loss of.
DR. CHRISTINA RUNDI MINISTRY OF HEALTH, MALAYSIA.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
TUBERCOLOSIS Agis Terzidis, Paediatrician Spyridon Gialamas, Medical Doctor SEMINAR ON TROPICAL AND TRAVEL MEDICINE AT TTCIH IFAKARA 25 JUNE 2009.
Comprehensive M&E Systems
Proceedings of the SAGE Working Group on Rubella Vaccines Susan E. Reef, MD Global Measles and Rubella Management Meeting March 15, 2011.
Use of epidemiologic methods in disaster management Dr AA Abubakar Dept of Community Medicine Ahmadu Bello University Zaria Nigeria.
African Project Implementation of the 2008 System of National Accounts.
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
Departmental Perspectives on Viral Hepatitis
Cross Border Animal Health Plan of Action – Kenya and Uganda Four Strategic areas 1. To improve prevention, management and control of cross border animal.
Roll Back Malaria Monitoring & Evaluation Reference Group (MERG) RBM 12 th Partnership Board Meeting Geneva, May 10-11, 2007 Bernard Nahlen Bernard Nahlen.
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
1 | Global Immunization Meeting: PIA Sitges, June 2015 New tools and strategies for maternal and neonatal tetanus and measles/rubella elimination.
INTOSAI Working Group on Public Debt Annual Meeting, May, 2013 Santiago, Chile Presented by: Shefali S Andaleeb.
Multi-Year Plans Strengthening immunization systems and introduction of hepatitis B vaccine in Central Europe and the Newly Independent States St. Petersburg,
Palestine Bahrain Global Measles and Rubella Management Meeting Boubker Naouri March, 2011 Geneva, WHO HQ.
Omondi Robert Sadia University of Nairobi
Conclusions of the meeting and closing remarks. Chronology 1981Hepatitis B vaccine becomes available 1991World Health Assembly resolution call for the.
Measles Initiative Management and Financing September 13, 2011.
Result of gap analysis and framework of action required in coming five months August rd Meeting of National Influenza Centres in the Western.
2003 Pan American Health Organization.... Roles and Responsibilities Branka Legetic, PAHO-WHO Regional Advisor STEPS STROKE training Curacao 15,16 November.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
Funding Update: 2013 – 2015 September 10,
WHO Regional Office for Europe Update on WHO GAVI European Regional Working Group and hepatitis B Immunization Viral Hepatitis Prevention Board Meeting.
Measles pre-elimination in the African Region. Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
1 st Workshop on issues and trends arising from the European IRRS missions Findings and Conclusions A.Munuera Brussels, 22 nd and 23 rd January 2014.
1 |1 | Measles pre-elimination and resurgence in the African region Balcha Masresha IVD AFRO Global Measles Management Meeting Geneva March 2011.
New Vaccines in Developing Countries: Evidence, Practice, Policy, and Challenges Global Vaccines 202X: Access, Equity, Ethics Philadelphia, USA 2 May 2011.
Strengthening Cause-of-death Information in countries through Africa Programme on Accelerated Improvement of Civil Registration and Vital Statistics System.
EHA Presentation Meeting of Health Ministers of Small Island Developing States Cape Verde 17 – 19 March, 2009.
Developing experience and evidence in surveillance implementation in Tanzania Dr. Patrick Swai USAID/Tanzania.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
2015 Measles & Rubella Initiative Annual Partners Meeting, Human & Financial Costs of Measles and Rubella, 15 September 2015, Washington, DC Achieving.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
Measles and Rubella Initiative Financial Resource Requirements for Measles and Rubella Annual Partners Meeting, September
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Midterm Review Update Global Measles and Rubella Strategic Plan 2012 – 2020 W. A. Orenstein, MD Measles and Rubella Management Meeting, Geneva, June 2016.
Improving health worldwide Implications for Monitoring of the HIV Care Cascade? Jim Todd MeSH Satellite Session IAS Durban, Monday 18 th.
One Health Symposium for South Asia Progress So Far Roger Morris.
Inclusive Education for Children with Disabilities
Response to the Yellow Fever Outbreak in the WHO African Region: What has been done? Dr Ambrose Talisuna, WHO-Regional Office for Africa-AFRO Brazzaville-Congo.
Innovations: Measles Programmatic Risk Assessments
WHO Operational Plan for RSV Surveillance Pilot
Roles and Responsibilities of VDH Epidemiologists
53 Member States >900 million inhabitants WHO European Region
Midterm Review of the Global Measles and Rubella Strategic Plan 2012 – 2020 Summary of the Findings and Implementation Status Dr Kaushik Banerjee M&RI.
World Health Organization
Measles & Rubella Initiative Partners meeting September 7-8, 2017
World Health Organization
National health policy review
Session 1: New Opportunities and New Direction
23 November, 2018 Update on measles & rubella surveillance in the WHO African Region – progress and challenges Dr Richard Luce WHO/IST-Central 5th African.
Stakeholder Consultation
African Region- priorities to reach the 2020 measles elimination goal.
Experience with the measles outbreak response fund
Objectives of Session Provide an overview of the development of Compendium Explain the organization of the Compendium and how indicators are used Provide.
Funding Update: Current Situation and Future Prospects
Introduction to public health surveillance
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
Comprehensive M&E Systems
Engagement Strategies for Monitoring & Evaluation
How are programmes specifically designed using collected data?
Presentation transcript:

Recap of the Midterm Review Recommendations Accelerating Progress towards Measles and Rubella Control/Elimination Goals 21 June 2016 Kaushik Banerjee

Overarching conclusion There is an urgent need to strengthen the collection and use of surveillance data to better guide program strategy and implementation

Surveillance - challenges Case investigation data often incomplete No hospitalization, death, economic burden data requested, limiting the use of data for advocacy Global outbreak investigation protocol is basic Cannot determine who is giving disease to whom Translation of data to programmatic change often weak

Surveillance recommendations ….(1) A working group on surveillance and outbreak investigation should be developed Protocols need to be developed to guide how to conduct, interpret and disseminate data analysis results for policy For example: who is transmitting to whom Exposure settings

Surveillance recommendations….(2) Sera collected to investigate cases of rash illness with fever to diagnose measles should be tested for rubella if found to be negative for measles, or tested for both at the same time Training materials should be developed for use at global, regional and country levels to design and improve systems to collect both surveillance data and perform outbreak investigations and interpret data and disseminate results to all levels of the system

Outbreak preparedness and response – findings Successes Existence of USD 10 million annual fund for ORI in Gavi-eligible countries Challenges Outbreak investigations need to be expanded to understand why they occurred and serve as advocacy tools Use of data from investigations needs to be improved to guide strategy and program Funding for non-Gavi and Gavi-graduating countries is desperately needed Bullet one: Theoretically the fund could be used for investigation, but in practice it always ends up being used for outbreak response.

Outbreak preparedness and response – recommendations ….(1) All measles outbreaks should be promptly investigated and used to develop a susceptibility profile of the population A clear definition of what constitutes an outbreak is required Training materials should be developed for use at global, regional and country levels to perform outbreak investigations, as well as to understand the underlying reasons that outbreaks are occurring and disseminate investigation results. Second bullet: Regions have definitions of outbreaks, but these vary by region. The regional definition varies depending on the level of control in the region.

Outbreak preparedness and response – recommendations ….(2) Guidance should be developed to allow countries to assess the economic burden of outbreaks. Information on cost and disruptiveness of outbreaks should be used as an advocacy tool There must be adequate financial, human and laboratory resources to conduct outbreak investigations Gavi-eligible countries should consider HSIS funds Resources are urgently needed for non-Gavi eligible countries Countries should develop outbreak preparedness plans. These should be assessed by RVCs.

Discussion